Kowa Company, Ltd.
↗Nagoya, Japan
Kowa Company, Ltd. is a major, privately-held Japanese conglomerate founded in 1894. While it operates across diverse sectors including textiles, optics, and general trading, its Pharmaceutical Business Unit is its most significant global division. Kowa Pharmaceuticals focuses on the research, development, and commercialization of therapies for cardiovascular, metabolic, and ophthalmological diseases.
The company is globally recognized for the development of the blockbuster statin Livalo (pitavastatin) and has a robust R&D infrastructure centered at its Tokyo New Drug Research Laboratories and Fuji Research Laboratories. Kowa operates internationally through subsidiaries such as Kowa Pharmaceuticals America (KPA) and Kowa Research Institute (KRI), maintaining a strong presence in the cardiometabolic market.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Cardiovascular and Ophthalmology therapeutics
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$3B-$4B
Founded:1894
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Pitavastatin, Pemafibrate)
Modalities:Small molecule, OTC drugs
Active Trials:12
Trial Phases:Phase 1: 3 | Phase 2: 4 | Phase 3: 5
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Kowa Pharmaceuticals America, Inc., Kowa Research Institute, Inc., Kowa Pharmaceutical Europe Co. Ltd., Riccovita Company, Ltd.
Key Partnerships:Nicox (Glaucoma treatment NCX 470), Eli Lilly (Historical co-promotion), Harvard University (Center for Interdisciplinary Cardiovascular Sciences)
COMPETITION
Position:Leader
Competitors:Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo, Amgen, Regeneron
LEADERSHIP
Key Executives:
Yoshihiro Miwa - Chairman, President & CEO
Board Members:Shigeru Kimura (Vice Chairman), Junichi Kawagoe (Vice Chairman), Naoki Miwa (Senior Managing Executive Officer)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kowa Company, Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.